4//SEC Filing
Gloria Melanie 4
Accession 0001764013-25-000057
CIK 0001764013other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:53 PM ET
Size
7.5 KB
Accession
0001764013-25-000057
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Gloria Melanie
Chief Operating Officer
Transactions
- Award
Common Stock
2025-04-01+76,181→ 186,137 total - Award
Stock Option (right to buy)
2025-04-01+107,297→ 107,297 totalExercise: $15.20Exp: 2035-04-01→ Common Stock (107,297 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 1, 2026, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
- [F2]The shares underlying the options will vest as to 25% of the shares on April 1, 2026 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001973838
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:53 PM ET
- Size
- 7.5 KB